Access Statistics for Diego Useche

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are patents signals for the IPO market? An EU–US comparison for the software industry 0 0 0 0 0 0 7 40
Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital 0 0 0 0 1 1 7 19
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 1 7 15
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 0 2 13
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 0 2 22
Empirical Economic Analysis of Orphan Drug Legislation Impact on Innovation 0 0 0 0 0 1 9 42
Empirical economic analysis of orphan drug legislation impact on innovation 0 0 0 0 0 1 4 420
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 0 0 1 3 14 31
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 0 0 0 3 12 24
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 0 0 1 3 21 40
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 0 0 1 7 13
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 0 0 0 4 9
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 0 0 0 6 34
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 48 0 2 14 104
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies 0 0 0 16 1 1 9 126
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies. NBER working paper n° w24021 0 0 0 0 0 1 7 15
Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies 0 0 0 0 0 0 8 26
Orphan Drug Designations as valuable Intangible assets for IPO Investors in Pharma-Biotech Companies 0 0 0 0 0 1 12 58
Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms 0 0 0 7 0 0 7 26
Total Working Papers 0 0 0 71 4 19 159 1,077


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are patents signals for the IPO market? An EU–US comparison for the software industry 1 2 3 47 2 6 37 204
Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital 0 0 2 10 1 3 23 74
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 0 24 0 2 24 120
Patenting Behaviour and the Survival of Newly Listed European Software Firms 0 0 0 8 0 0 17 54
Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms 0 1 2 10 1 4 15 48
Total Journal Articles 1 3 7 99 4 15 116 500


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies 0 0 0 14 1 3 18 103
Total Chapters 0 0 0 14 1 3 18 103


Statistics updated 2026-08-07